NOX 4.17% 6.9¢ noxopharm limited

Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-14

  1. 7,515 Posts.
    lightbulb Created with Sketch. 337
    "...Drugs That Work In Mice Often Fail When Tried In People

    Most potential new drugs fail when they're tested in people. These failures are not only a major disappointment, they sharply drive up the cost of developing new drugs.
    A major reason for these failures is that most new drugs are first tested out in mice, rats or other animals. Often those animal studies show great promise.
    But mice aren't simply furry little people, so these studies often lead science astray.
    Some scientists are now rethinking animal studies to make them more effective for human health. When scientists first started using animals in research over a century ago, the animals were not regarded as human stand-ins. Scientists studying rats were initially trying to understand rats..."


    https://www.npr.org/sections/health-shots/2017/04/10/522775456/drugs-that-work-in-mice-often-fail-when-tried-in-people
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.